Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Dennis Leo Walsh currently holds 4,727 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis Leo Walsh has been a net buyer of DCPH stock. They have purchased $152.5K and sold $0 worth of shares.
Dennis Leo Walsh's most recent insider trade was on Jun 11, 2024, when they sold 9,570 shares at $0.00 per share.
Dennis Leo Walsh serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 10 insider transactions totaling $152.5K over their tenure at the company.
Dennis Leo Walsh holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Dennis Leo Walsh has shown a buying trading pattern, with $152.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Dennis Leo Walsh was on May 10, 2023, when they purchased $152.5K worth of DCPH shares. This transaction involved 11,000 shares at $13.86 per share.
Dennis Leo Walsh currently owns 4,727 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Dennis Leo Walsh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Dennis Leo Walsh has 10 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Dennis Leo Walsh and 40,000+ other insiders.